SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $494,000 | -65.2% | 26,000 | -69.9% | 0.03% | -57.9% |
| Q4 2017 | $1,418,000 | +200.4% | 86,500 | +10.8% | 0.08% | +58.3% |
| Q1 2016 | $472,000 | +26.5% | 78,100 | +17.6% | 0.05% | 0.0% |
| Q3 2015 | $373,000 | -49.3% | 66,400 | 0.0% | 0.05% | -53.4% |
| Q2 2015 | $735,000 | +129.0% | 66,400 | +273.0% | 0.10% | +106.0% |
| Q1 2014 | $321,000 | – | 17,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |